UBS Group AG - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 43 filers reported holding SIO GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q4 2022$35,244
+3424.4%
80,100
+1669.4%
0.00%
Q3 2022$1,000
-95.0%
4,527
-91.8%
0.00%
Q2 2022$20,000
-23.1%
55,529
+169.4%
0.00%
Q4 2021$26,000
-75.9%
20,613
-50.3%
0.00%
Q1 2021$108,000
+315.4%
41,500
+341.4%
0.00%
Q4 2020$26,0009,4010.00%
Other shareholders
SIO GENE THERAPIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sassicaia Capital Advisers LLC 310,500$863,0001.79%
Consonance Capital Management LP 3,186,335$8,858,0000.83%
Opaleye Management Inc. 2,000,000$5,560,0000.73%
Sio Capital Management, LLC 886,665$2,465,0000.50%
Rubric Capital Management LP 2,335,200$6,492,0000.48%
Affinity Asset Advisors, LLC 250,000$695,0000.37%
GSA CAPITAL PARTNERS LLP 354,265$985,0000.16%
Hudson Bay Capital Management LP 3,200,000$8,896,0000.05%
Insight Advisors, LLC/ PA 24,000$67,0000.02%
Maven Securities LTD 86,788$246,0000.02%
View complete list of SIO GENE THERAPIES INC shareholders